
Join to View Full Profile
321 E Warwick Dr Ste CAlma, MI 48801
Phone+1 989-463-9300
Dr. Almahariq is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Muayad Almahariq is a radiation oncologist in Dearborn, MI and is affiliated with Beaumont Hospital - Dearborn and Beaumont Hospital-Royal Oak. He received his medical degree from University of Texas Medical Branch and has been in practice 5 years. He is experienced in proton beam therapy, intensity-modulated radiation therapy, linac radiosurgery, gamma knife radiosurgery, and stereotactic body radiotherapy.
Education & Training
- Corewell Health William Beaumont University HospitalResidency, Radiation Oncology, 2016 - 2021
- University of Texas Medical Branch School of MedicineClass of 2016
Certifications & Licensure
- IL State Medical License 2022 - 2026
- MI State Medical License 2016 - 2025
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Regional Near-Surface Dose Predicts Moist Desquamation and Implant Failure in Patients Receiving Radiation Therapy for Breast Cancer.Kamran Salari, Joseph S Lee, Derek A Mumaw, Muayad F Almahariq, Thomas J Quinn
International Journal of Radiation Oncology, Biology, Physics. 2025-08-01 - Optimizing posterior neck coverage in regional nodal irradiation for breast cancer.Jacob F Oyeniyi, Bailey A Loving, Thomas J Quinn, Muayad F Almahariq, Joshua T Dilworth
Medical Dosimetry. 2025-04-29 - 1 citationsLeveraging technology and standardized institutional practices to mitigate disparities in breast cancer radiation therapy.Jacob F Oyeniyi, Bailey A Loving, Muayad F Almahariq, Maha Saada Jawad, Joshua T Dilworth
Cancer Causes & Control. 2025-03-19
Press Mentions
- Regional near-Surface Dose Predicts Moist Desquamation and Implant Failure in Patients Receiving Radiation Therapy for Breast CancerFebruary 24th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: